Join to View Full Profile
8008 Frost StSte 401San Diego, CA 92123
Phone+1 858-309-5831
Fax+1 858-810-6908
Dr. Willms is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Willms is a pulmonologist based in San Diego, CA, with subspecialty in critical care medicine. He completed his medical education at Baylor College of Medicine and further training in internal medicine and pulmonary disease at University of Texas Health Science Center and University of California (San Diego) Medical Center. His areas of expertise include acute respiratory distress syndrome, respiratory failure, sepsis, critical care medicine, and mechanical ventilation. Dr. Willms has contributed to several publications, including studies on core warming in COVID-19 patients, Heliox therapy, ARDS, and extracorporeal membrane oxygenation. He is recognized as a Fellow by the American College of Critical Care Medicine.
Education & Training
University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1988
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1982 - 1985- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1982 - 1983
Baylor College of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1985 - 2027
TX State Medical License 1983 - 1989
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellow (FCCM) American College of Critical Care Medicine
Clinical Trials
- Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia Start of enrollment: 2007 Nov 01
- Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation Start of enrollment: 2020 Aug 19
Publications & Presentations
PubMed
- 3 citationsCore Warming of Coronavirus Disease 2019 Patients Undergoing Mechanical Ventilation: A Pilot Study.Nathaniel P Bonfanti, Nicholas M Mohr, David C Willms, Roger J Bedimo, Emily Gundert
Therapeutic Hypothermia and Temperature Management. 2023-12-01 - 3 citationsThe Southern California Extracorporeal Membrane Oxygenation Consortium During the Coronavirus Disease 2019 Pandemic.Mazen Odish, Cassia Yi, Juliann Eigner, Amelia Kenner Brininger, Kristi L. Koenig
Disaster Medicine and Public Health Preparedness. 2021-06-08 - 27 citationsRandomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.Matthew Geriak, Fadi Haddad, Ravina Kullar, Kristina L Greenwood, MacKenzie Habib
Infectious Diseases and Therapy. 2021-05-11
Press Mentions
66: Crash VV ECMOSeptember 7th, 2020- Pilot Study to Investigate Use of Attune Medical’s ensoETM for COVID-19 Treatment Enrolls First Patient at Sharp Memorial Hospital in San DiegoAugust 26th, 2020
Young Man Saved by ECMO After Being Found FrozenJanuary 21st, 2016- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
